Read + Share
Amedeo Smart
Independent Medical Education
Han Z, Liu L, Jiang Y. Suggestions for the predictive factors related to irAES and research methods during dose switching of pembrolizumab treatment in patients with advanced NSCLC. J Thorac Oncol 2024;19:e31-e32.PMID: 39242141
Email
LinkedIn
Privacy Policy